INVO Fertility (IVF) Gains from Investment Securities (2020 - 2024)
INVO Fertility (IVF) has disclosed Gains from Investment Securities for 5 consecutive years, with $50000.0 as the latest value for Q2 2024.
- Quarterly Gains from Investment Securities rose 2031.29% to $50000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was -$511663.0 through Dec 2024, changed N/A year-over-year, with the annual reading at -$511663.0 for FY2024, N/A changed from the prior year.
- Gains from Investment Securities for Q2 2024 was $50000.0 at INVO Fertility, up from -$561663.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $1.5 million in Q2 2022, with the low at -$561663.0 in Q1 2024.
- Average Gains from Investment Securities over 5 years is $510312.1, with a median of $56509.0 recorded in 2020.
- The sharpest move saw Gains from Investment Securities soared 161589.14% in 2022, then plummeted 139.76% in 2024.
- Over 5 years, Gains from Investment Securities stood at $56509.0 in 2020, then plummeted by 95.76% to $2395.0 in 2021, then soared by 317.54% to $10000.0 in 2022, then increased by 9.73% to $10973.0 in 2023, then skyrocketed by 355.66% to $50000.0 in 2024.
- According to Business Quant data, Gains from Investment Securities over the past three periods came in at $50000.0, -$561663.0, and $10973.0 for Q2 2024, Q1 2024, and Q3 2023 respectively.